Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00262-004-0581-1.

Title:
Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer | Cancer Immunology, Immunotherapy
Description:
MUC1 is a glycoprotein overexpressed in tumors as a hypoglycosylated form. A vaccine composed of a 100–amino acid peptide corresponding to five 20–amino acid long repeats, and SB-AS2 adjuvant, was tested in a phase I study for safety, toxicity, and ability to elicit or boost MUC1-specific immune responses. Patients with resected or locally advanced pancreatic cancer without prior chemotherapy or radiotherapy were eligible. Escalating doses of the peptide (100, 300, 1,000, and 3,000 μg) were admixed with SB-AS2 and administered intramuscularly every 3 weeks for three doses, in cohorts of four patients. Sixteen patients were enrolled. Common adverse effects were grade 1 flu-like symptoms, tenderness, and erythema at the injection site. Delayed-type hypersensitivity (DTH) sites showed few or no T cells prevaccination (Pre V), but increased T-cell infiltration postvaccination (Post V). There was an increase in the percentage of CD8+ T cells in the peripheral blood Post V. An increase in total MUC1-specific antibody was seen in some patients, and several patients developed IgG antibody. Two of 15 resected pancreatic cancer patients are alive and disease free at follow-up of 32 and 61 months. MUC1 100mer peptide with SB-AS2 adjuvant is a safe vaccine that induces low but detectable mucin-specific humoral and T-cell responses in some patients. No difference was seen between different peptide doses. Further evaluation is warranted to examine the effect on disease-free survival and overall survival, especially in early disease and in the absence of immunosuppressive standard therapy.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Health & Fitness
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 7,642,828 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We're unsure how the site profits.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com could have a money-making trick up its sleeve, but it's undetectable for now.

Keywords {🔍}

cancer, pubmed, google, scholar, cas, article, pancreatic, finn, muc, peptide, patients, vaccine, pittsburgh, phase, adjuvant, tumor, trial, immune, cells, access, res, usa, privacy, cookies, content, research, doses, sbas, tcell, vaccines, clin, immunol, information, publish, search, immunology, study, resected, advanced, lee, elizabeth, responses, mucin, clinical, university, data, log, journal, composed, locally,

Topics {✒️}

month download article/chapter granulocyte-derived hydrogen peroxide tumor-selective monoclonal antibody detectable mucin-specific humoral focused th1-type cellular total muc1-specific antibody simulation-based multiple comparisons nih/ncrr/gcrc/grant cytotoxic t-cell responses immunosuppressive standard therapy therapeutic cancer vaccines barratt-boyes sm tandem repeat eitope pancreatic cancer research human mucin muc-1 100–amino acid peptide specific immune reactivity t-cell responses muc1 100mer peptide muc1 vaccine composed humoral immune responses related subjects article cancer immunology resectable pancreatic cancer full article pdf clinical trial designs vaccines based cancer vaccines privacy choices/manage cookies semi-immune adults clinical oncology meeting pancreatic cancer patients t-cell function tg mice challenged early clinical development advanced cancer patients delayed-type hypersensitivity upmc health system muc1 peptide randomised controlled trial european economic area common adverse effects anti-pd-l1 de wit lt european study group nathan arenson fund dr clauidine bruck dr martin cheever upci biostatistics facility colon cancer patients

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
         description:MUC1 is a glycoprotein overexpressed in tumors as a hypoglycosylated form. A vaccine composed of a 100–amino acid peptide corresponding to five 20–amino acid long repeats, and SB-AS2 adjuvant, was tested in a phase I study for safety, toxicity, and ability to elicit or boost MUC1-specific immune responses. Patients with resected or locally advanced pancreatic cancer without prior chemotherapy or radiotherapy were eligible. Escalating doses of the peptide (100, 300, 1,000, and 3,000 μg) were admixed with SB-AS2 and administered intramuscularly every 3 weeks for three doses, in cohorts of four patients. Sixteen patients were enrolled. Common adverse effects were grade 1 flu-like symptoms, tenderness, and erythema at the injection site. Delayed-type hypersensitivity (DTH) sites showed few or no T cells prevaccination (Pre V), but increased T-cell infiltration postvaccination (Post V). There was an increase in the percentage of CD8+ T cells in the peripheral blood Post V. An increase in total MUC1-specific antibody was seen in some patients, and several patients developed IgG antibody. Two of 15 resected pancreatic cancer patients are alive and disease free at follow-up of 32 and 61 months. MUC1 100mer peptide with SB-AS2 adjuvant is a safe vaccine that induces low but detectable mucin-specific humoral and T-cell responses in some patients. No difference was seen between different peptide doses. Further evaluation is warranted to examine the effect on disease-free survival and overall survival, especially in early disease and in the absence of immunosuppressive standard therapy.
         datePublished:2004-09-14T00:00:00Z
         dateModified:2004-09-14T00:00:00Z
         pageStart:254
         pageEnd:264
         sameAs:https://doi.org/10.1007/s00262-004-0581-1
         keywords:
            Clinical trial
            Immune response
            Pancreatic cancer
            Peptide vaccine
            Oncology
            Immunology
            Cancer Research
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb1.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb2.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb3.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1flb4.gif
         isPartOf:
            name:Cancer Immunology, Immunotherapy
            issn:
               1432-0851
               0340-7004
            volumeNumber:54
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Ramesh K. Ramanathan
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kenneth M. Lee
               affiliation:
                     name:UPMC Health System
                     address:
                        name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:John McKolanis
               affiliation:
                     name:University of Pittsburgh School of Medicine
                     address:
                        name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elizabeth Hitbold
               affiliation:
                     name:University of Pittsburgh School of Medicine
                     address:
                        name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Wolfgang Schraut
               affiliation:
                     name:UPMC Health System
                     address:
                        name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Arthur J. Moser
               affiliation:
                     name:UPMC Health System
                     address:
                        name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Elizabeth Warnick
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Theresa Whiteside
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:Hillman Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jennifer Osborne
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Hyoung Kim
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Roger Day
               affiliation:
                     name:The UPCI Biostatistics Facility
                     address:
                        name:The UPCI Biostatistics Facility, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Monica Troetschel
               affiliation:
                     name:University of Pittsburgh Cancer Institute
                     address:
                        name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Olivera J. Finn
               affiliation:
                     name:University of Pittsburgh School of Medicine
                     address:
                        name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Phase I study of a MUC1 vaccine composed of different doses of MUC1 peptide with SB-AS2 adjuvant in resected and locally advanced pancreatic cancer
      description:MUC1 is a glycoprotein overexpressed in tumors as a hypoglycosylated form. A vaccine composed of a 100–amino acid peptide corresponding to five 20–amino acid long repeats, and SB-AS2 adjuvant, was tested in a phase I study for safety, toxicity, and ability to elicit or boost MUC1-specific immune responses. Patients with resected or locally advanced pancreatic cancer without prior chemotherapy or radiotherapy were eligible. Escalating doses of the peptide (100, 300, 1,000, and 3,000 μg) were admixed with SB-AS2 and administered intramuscularly every 3 weeks for three doses, in cohorts of four patients. Sixteen patients were enrolled. Common adverse effects were grade 1 flu-like symptoms, tenderness, and erythema at the injection site. Delayed-type hypersensitivity (DTH) sites showed few or no T cells prevaccination (Pre V), but increased T-cell infiltration postvaccination (Post V). There was an increase in the percentage of CD8+ T cells in the peripheral blood Post V. An increase in total MUC1-specific antibody was seen in some patients, and several patients developed IgG antibody. Two of 15 resected pancreatic cancer patients are alive and disease free at follow-up of 32 and 61 months. MUC1 100mer peptide with SB-AS2 adjuvant is a safe vaccine that induces low but detectable mucin-specific humoral and T-cell responses in some patients. No difference was seen between different peptide doses. Further evaluation is warranted to examine the effect on disease-free survival and overall survival, especially in early disease and in the absence of immunosuppressive standard therapy.
      datePublished:2004-09-14T00:00:00Z
      dateModified:2004-09-14T00:00:00Z
      pageStart:254
      pageEnd:264
      sameAs:https://doi.org/10.1007/s00262-004-0581-1
      keywords:
         Clinical trial
         Immune response
         Pancreatic cancer
         Peptide vaccine
         Oncology
         Immunology
         Cancer Research
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb1.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb2.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1fhb3.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00262-004-0581-1/MediaObjects/s00262-004-0581-1flb4.gif
      isPartOf:
         name:Cancer Immunology, Immunotherapy
         issn:
            1432-0851
            0340-7004
         volumeNumber:54
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Ramesh K. Ramanathan
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kenneth M. Lee
            affiliation:
                  name:UPMC Health System
                  address:
                     name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:John McKolanis
            affiliation:
                  name:University of Pittsburgh School of Medicine
                  address:
                     name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elizabeth Hitbold
            affiliation:
                  name:University of Pittsburgh School of Medicine
                  address:
                     name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Wolfgang Schraut
            affiliation:
                  name:UPMC Health System
                  address:
                     name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Arthur J. Moser
            affiliation:
                  name:UPMC Health System
                  address:
                     name:Department of Surgery, UPMC Health System, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Elizabeth Warnick
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Theresa Whiteside
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:Hillman Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jennifer Osborne
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Hyoung Kim
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Roger Day
            affiliation:
                  name:The UPCI Biostatistics Facility
                  address:
                     name:The UPCI Biostatistics Facility, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Monica Troetschel
            affiliation:
                  name:University of Pittsburgh Cancer Institute
                  address:
                     name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Olivera J. Finn
            affiliation:
                  name:University of Pittsburgh School of Medicine
                  address:
                     name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Cancer Immunology, Immunotherapy
      issn:
         1432-0851
         0340-7004
      volumeNumber:54
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Pittsburgh Cancer Institute
      address:
         name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:UPMC Health System
      address:
         name:Department of Surgery, UPMC Health System, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh School of Medicine
      address:
         name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh School of Medicine
      address:
         name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
         type:PostalAddress
      name:UPMC Health System
      address:
         name:Department of Surgery, UPMC Health System, Pittsburgh, USA
         type:PostalAddress
      name:UPMC Health System
      address:
         name:Department of Surgery, UPMC Health System, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:Hillman Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:The UPCI Biostatistics Facility
      address:
         name:The UPCI Biostatistics Facility, USA
         type:PostalAddress
      name:University of Pittsburgh Cancer Institute
      address:
         name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
         type:PostalAddress
      name:University of Pittsburgh School of Medicine
      address:
         name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Ramesh K. Ramanathan
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Kenneth M. Lee
      affiliation:
            name:UPMC Health System
            address:
               name:Department of Surgery, UPMC Health System, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:John McKolanis
      affiliation:
            name:University of Pittsburgh School of Medicine
            address:
               name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Elizabeth Hitbold
      affiliation:
            name:University of Pittsburgh School of Medicine
            address:
               name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Wolfgang Schraut
      affiliation:
            name:UPMC Health System
            address:
               name:Department of Surgery, UPMC Health System, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Arthur J. Moser
      affiliation:
            name:UPMC Health System
            address:
               name:Department of Surgery, UPMC Health System, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Elizabeth Warnick
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Theresa Whiteside
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:Hillman Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Jennifer Osborne
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Hyoung Kim
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Roger Day
      affiliation:
            name:The UPCI Biostatistics Facility
            address:
               name:The UPCI Biostatistics Facility, USA
               type:PostalAddress
            type:Organization
      name:Monica Troetschel
      affiliation:
            name:University of Pittsburgh Cancer Institute
            address:
               name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Olivera J. Finn
      affiliation:
            name:University of Pittsburgh School of Medicine
            address:
               name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:Department of Surgery, UPMC Health System, Pittsburgh, USA
      name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
      name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
      name:Department of Surgery, UPMC Health System, Pittsburgh, USA
      name:Department of Surgery, UPMC Health System, Pittsburgh, USA
      name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:Hillman Cancer Research Center, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:The UPCI Biostatistics Facility, USA
      name:UPMC Cancer Pavilion, University of Pittsburgh Cancer Institute, Pittsburgh, USA
      name:Department of Immunology, E1040 Biomedical Science Tower, University of Pittsburgh School of Medicine, Pittsburgh, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(101)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.51s.